INTRODUCTION
Influenza A viruses circulate in a wide variety of hosts, including birds, humans, pigs and other mammals (Webster et al., 1992) . Cross-species infection is thought to be the fundamental mechanism of initiation of human influenza pandemics (Webster, 2002) . In 1997, a highly pathogenic avian influenza (HPAI) H5N1 virus crossed the species barrier to directly transmit from birds to humans in Hong Kong and caused 18 cases of illness including six deaths (Claas et al., 1998) .
The haemagglutinin (HA) protein of all influenza viruses consists of two chains, HA1 and HA2. The HA1 mutates more frequently than HA2 (Plotkin & Dushoff, 2003) . Previous studies showed HPAI H5N1 cross-clade reactivity (Baras et al., 2008; Ducatez et al., 2011; Govorkova et al., 2006) , although H5N1 viruses differ at the antigenic level (Boon & Webby, 2009) . Distinct antigenic sites have been mapped to the globular head of HA by using sequence information from naturally occurring and laboratoryselected antigenic variants (Wiley et al., 1981; Wilson & Cox, 1990) . Antigenic analysis of H5 isolates showed a change in the reactivity pattern of the HA with polyclonal sera and mAbs, compatible with viral antigenic drift . This continuous evolution of H5N1 viruses and the emergence of new antigenic variants may be partially explained by immune pressure caused by the use of vaccines, which could have created a survival advantage for those H5 viruses that undergo antigenic variation. Such variants can circumnavigate vaccine-induced immunity and are called escape mutants (Carrat & Flahault, 2007; Escorcia et al., 2008) . The antigenic diversity of HPAI H5N1 viruses not only increases the difficulty of developing pre-pandemic vaccines but also creates diagnostic problems. These issues may affect the sensitivity of rapid influenza diagnostic tests based on antigenic characterization and molecular detection methods (Abdelwhab et al., 2010a (Saad et al., 2007) . In 2008, H5N1 was declared to be endemic in Egypt and the viruses in this country were reclassified as clade 2.2.1 (WHO/OIE/ FAO, 2009) . The endemicity of H5N1 viruses in Egypt was due to several factors related to vaccines, vaccination strategy, lax biosecurity measures and presence of the virus in different poultry sectors (Kayali et al., 2011a; Peyre et al., 2009) . Previous studies have classified Egyptian viruses from 2006 to 2010 into distinct sublineages based on genetic characterization (Abdel-Moneim et al., 2009; Balish et al., 2010; Eladl et al., 2011; Kayali et al., 2011b; Watanabe et al., 2011) . Sequence analysis of the HA gene segment of H5N1 viruses isolated in Egypt revealed different selection profiles and rates of nucleotide substitution (Cattoli et al., 2011) . Further divergence of contemporary strains of H5N1 circulating in Egyptian poultry (Kayali et al., 2011a) led to reclassification of these viruses into a fourth order clade 2.2.1.1 (WHO/OIE/FAO, 2012). In addition to genetic variation, Egyptian strains demonstrated significant antigenic drift within clade 2.2.1 (Balish et al., 2010; Grund et al., 2011; Rauw et al., 2011; Swayne & Kapczynski, 2008) .
In Egypt, several types of inactivated H5 vaccines (according to recent reports of the Egyptian General Organization for Animal Health there are 24 vaccines licensed in Egypt) produced by a number of commercial companies based on different Eurasian and American H5N2 and Eurasian H5N1 subtype viruses was used without rules to select the most potent and marketing control (Abdelwhab & Hafez, 2011; Aly et al., 2008; Hafez et al., 2010) . The immunogenicity of these commercial vaccines is evaluated in the Egyptian Central Laboratory for Evaluation of Veterinary Products in specific pathogen-free (SPF) chickens prior to release into the markets (Peyre et al., 2009) . The failure of poultry vaccination in Egypt may be partially caused by the passive transfer of maternal H5N1 antibodies to chicks that inhibit their immune response to vaccination (Abdelwhab et al., 2012; De Vriese et al., 2010; Kim et al., 2010) . Generation of escape mutants in poultry vaccinated against subtype H5 influenza A viruses was first observed in the follow-up phase of HPAIV H5N2 outbreaks in Mexico during the 1990s (Lee et al., 2004) . Mismatch between circulating strains and the vaccine strain in the subsequent season reduced effectiveness of the vaccine (Carrat & Flahault, 2007) . A recent study demonstrated that a vaccine based on different Eurasian and American H5N2 and Eurasian H5N1 subtype viruses failed to protect chickens against Egyptian H5N1 strain of clade 2.2.1.1 (Grund et al., 2011; Hassan et al., 2012; Rauw et al., 2011) .
Thus, there is an urgent need to understand not only the genetic, but more importantly the antigenic variations between the viruses detected in different seasons and geographical areas that are essential to assess efficacy of avian influenza virus (AIV) vaccination so vaccine strains can be properly selected. In this study, we characterized the antigenic variations in Egyptian H5N1 viruses based on their reactivity with monoclonal and polyclonal antibodies.
RESULTS

Antigenic analysis of H5N1 virus isolates
To characterize the antigenic variation of 33 isolates of H5N1 viruses, we tested the haemagglutination inhibition (HI) activity of a panel of anti-H5 mAbs prepared against different antigenic epitopes of A/Viet Nam/1203/04 (H5N1) influenza virus (VN04-2, VN04-8, VN04-9, VN04-10, VN04-13 and VN04-16) and A/bar-headed goose/QH/1A/05 (H5N1) (BHG05-1 and BHG05-2) against our isolates. According to antigenic sites recognized, the mAbs used in this study were divided into three groups ( Fig. 1) : group 1 (VN04-2, VN04-9, VN04-10 and VN04-16) targeting antigenic site B, group 2 (VN04-8, BHG05-1 and BHG05-2) targeting antigenic site A, and group 3 (VN04-13) exhibiting a complex pattern of specificity that overlapped both epitopes defined by groups 1 and 2 mAbs (Kaverin et al., 2007) . The results of HI assay were subjected to analysis by using the integrative matrix completion multi-dimensional scaling matrix completionmultidimensional scaling (MC-MDS) method (Cai et al., 2010) . The cartography of the HI assays showed that the H5N1 viruses fell into three clusters, A, B and C ( Fig. 1 For mAb VN04-2, previous HI assay data suggest an absolute requirement for lysine at position 140 (H5 numbering) of HA1 in antigenic site A (Chen et al., 2006; Hanson et al., 2006) , while Kaverin et al.(2007) showed that escape mutants selected from the homologous virus carried substitutions of R162G or S121Y with I151T. Most of the viruses analysed here showed low reactivity with this mAb probably due to K140G with S141P substitutions (cluster B) or K140R substitution (clusters A and C). overlapping epitopes within an antigenic site equivalent to site B in H3 HA (Kaverin et al., 2007) .
The HI results showed that mAb VN04-9 reacts relatively weakly with only three of the Egyptian viruses (Table 1) , while mAbs VN04-10 and VN04-16 react with all isolates from 2006 to the beginning of 2010 but do not react with later strains that, from sequencing analyses performed during the course of this study, uniquely carry HA1 amino acid substitutions compared with A/Viet Nam/1203/2004 of D43N, S120D, I151T, S155D (S155A in A/chicken/Egypt/ S3093A/2011) and G272S.
It was shown that A/Viet Nam/1203/2004 carrying single HA1 amino acid substitutions of K152E/N can escape these mAbs while in a different HA background, A/mallard/ Pennsylvania/10218/84 (H5N2), combinations of substitutions spanning positions 124-152 can result in escape (Kaverin et al., 2007) . The amino acid alignment shows that site B of all the HA proteins of the Egyptian H5N1 influenza viruses carry a substitution of S124D together with N154D (in A/chicken/Qalubia/1/2006 and A/chicken/Egypt/1/08), T156A (in cluster A, cluster C and A/chicken/Egypt/1/08), A184E (in cluster B) and S155N/D/A. For the latter substitution, 155N was present in all isolates having high reactivity with VN04-10 and VN04-16, while S155D, first appearing at the end of 2010, was present in viruses that did not react with VN04-10 and VN04-16.
VN04-8 selected a mutant carrying K140E substitution and it also failed to react with mutants carrying S141P/T/F or G139E substitutions selected by other VN04 mAbs (Kaverin et al., 2007) . In the present study, the VN04-8 mAb reacted with half of the Egyptian viruses tested (2006, 2007, duck/ 2010 and 2011) , and sequences available for five of the escapees, including A/duck/Egypt/M3075B/2011, showed that they carried the S141P substitution (Fig. 3) . Both the BHG05 mAbs showed similar reactivity profiles to VN04-8 (Table 1) .
The VN04-13 mAb selected mutants that carried substitutions of S141F or D183 with K189E and also failed to react with a mutant carrying T156A with K189E and showed reduced activity with mutants carrying S141P selected by other mAbs in the VN04 set (Kaverin et al., 2007) . This (Table 1) , of which four had the S141P substitution as did A/duck/Egypt/M3075B/2011, the only virus that had the combination of two substitutions, K140R and S141P (Fig. 3) . Polyclonal cross-reactivity analysis and phylogenetic tree
In the present study, we prepared rat hyperimmune sera raised against eight Egyptian H5N1 viruses, assessed to be antigenically different with the mAbs panel, to evaluate antigenic reactivity. Cartography of the HI assay results showed extensive overlap, indicating that shared epitopes were found in all virus isolates (Fig. 4) .
Antisera raised against A/chicken/Qalubia/1/2006 were poorly reactive with all isolates except itself (Fig. 5 , Table S1 ).
We also selected two viruses from 2011. A/goose/Egypt/ M2794A/2011 antiserum reacted strongly with all viruses, except for A/chicken/Egypt/S3280B/2011 and A/chicken/ Egypt/S3280D/2011 which carry V148I substitutions. A/ duck/Egypt/M3075B/2011 antiserum gave a relatively low homologous titre but reacted moderately with all viruses (Fig. 5 , Table S1 ).
A phylogenetic analysis of amino acid sequences of the fulllength HA of Egyptian H5N1 viruses is shown in (Fig. 6 ). The antigenic clusters, A, B and C, identified by antigenic cartography analysis of the mAbs panel HI results ( Fig. 1) can be identified on the phylogenetic tree.
DISCUSSION
In the present study, we evaluated the antigenic variations and immunogenicity of some HPAI H5N1 virus strains that were isolated from Egypt between 2006 and 2011 and determined the antigenic drift from season to season. Since 2008, when the virus was declared endemic in Egypt these viruses have mutated rapidly and caused varying symptoms among domestic poultry (Hafez et al., 2010; Kayali et al., 2011a) . We analysed 33 virus isolates by HI assays with a panel of mAbs recognizing HA antigenic sites A and B, which revealed that the HPAI H5N1 that infected Egyptian poultry and became endemic have evolved to produce different antigenic variants. These variants fell into three antigenic clusters (A-C) with variable distances between each other according to the year of isolation. All clusters are made up of mixed isolates from different years, indicating some sharing in antigenic epitopes. Cluster B contains 86.6 % (13/15) of the 2010 isolates, and cluster C has 31.25 % (5/16) of the 2010 isolates and 68.75 % (11/16) of the 2011 ones. In addition, research showed that at least two subgroups of H5N1 viruses circulate together in Egypt. One group resembles the original 2006 virus and another group of vaccine escape mutants (Abdelwhab et al., 2010b; Arafa et al., 2010; Kayali et al., 2011a) . The phylogenetic tree (Fig. 6) Therefore, it may be advisable to select vaccine candidates that represent antigenic clusters B and C, which embody all virus isolates that circulated in 2010 and 2011 as shown in the phylogenetic tree of the HA gene of all Egyptian H5N1 HA genes submitted to GenBank (Fig. 6) . The efficacy of any selected vaccine should be tested in the field for immunogenicity and protection (effectiveness) under challenge experiments, before widespread use in commercial flocks.
The clade classification system was established on the basis of phylogenetic analysis. Although H5N1 isolates were assigned to clades or subclades depending on antigenic relatedness, very few studies have thoroughly investigated the antigenic cross-reactivity among HPAI H5N1 viruses (Ducatez et al., 2011) . When H5N1 emerged in Egypt in 2006, it was classified as clade 2.2, but by 2008 it was reclassified as clade 2.2.1 and declared to be endemic. Many studies have classified viruses from 2006 to 2010 into distinct sublineages based on genetic characterization (Cattoli et al., 2011; Eladl et al., 2011; Kayali et al., 2011a; Watanabe et al., 2011) . As recommended by WHO/OIE/FAO H5N1 Evolution Working Group 2012, the Egyptian third-order clade 2.2.1 also required splitting into a new clade 2.2.1.1, indicating further divergence of contemporary strains of H5N1 circulating in Egyptian poultry (Kayali et al., 2011b; WHO/ OIE/FAO, 2012) .
The continuous antigenic drift of the HA protein necessitates constant surveillance so that vaccines can be updated to provide effective coverage against the current strains (Swayne, 2006 (Swayne, , 2009 . Extensive vaccination of chickens with H5N2-based inactivated vaccine has been shown to produce the emergence of vaccine escape mutants in Mexico (Lee et al., 2004) . Thus, sustained viral sequence comparisons and assessment of antigenic diversity of circulating HPAIV H5N1 are necessary to recognize newly emerging influenza variants and to monitor the spread of such viruses. In Egypt, biosecurity measures are applied on large private and governmental farms, but are lax on many small farms and in backyards. Therefore, vaccination with vaccines that are well-matched to currently circulating viruses should be one of the main tools for virus reduction regardless of evolutionary rates.
METHODS
Isolation and propagation of viruses. A total of 33 virus isolates were collected from 2006 to 2011 from different Egyptian governorates. The samples were collected from chickens, turkeys, geese and ducks. Cloacal and oropharyngeal swabs were collected and stored at 280 uC. Viral RNA was extracted from 140 ml of collected samples by using a QIAamp viral RNA mini kit (Qiagen) according to the manufacturer's protocol in a class III bio-safety cabinet. The extracted RNA was aliquoted and kept at 280 uC. To detect influenza A, extracted RNA was subjected to RT-PCR to amplify 244 bp of the M gene of influenza A viruses according to a WHO protocol (WHO, 2009) . Samples that were positive for M-gene were then subjected to additional RT-PCR for subtyping analysis.
All the detected influenza viruses were inoculated in 10 day-old SPF embryonated chicken eggs (SPF Eggs Production Farm, Agricultural Research Center, Ministry of Agriculture, Egypt) and incubated for 24 h at 37 uC, then chilled at 4 uC for 4 h before harvesting. The allantoic fluid was harvested, clarified, tested for haemagglutination and then stored at 280 uC until use. mAbs. A panel of six anti-H5 mAbs (VN04-2, VN04-8, VN04-9, VN04-10, VN04-13 and VN04-16) were prepared against different antigenic epitopes of A/Viet Nam/1203/04 (H5N1) influenza virus and two mAbs (BHG05-1 and BHG05-2) raised against A/bar-headed goose/QH/1A/05 (H5N1). mAbs were prepared at St. Jude Children's Research Hospital and used to antigenically characterize the different virus isolates using HI assay. HA genes of the selected HPAI H5N1 viruses were modified to remove the encoded polybasic cleavage sites and low-pathogenicity vaccine viruses containing the HA (modified) and NA genes of the isolates and the six internal genes of A/Puerto Rico/8/34 were generated by reverse genetics (Webby et al., 2004) . Rescued viruses were propagated in 10 day-old embryonated chicken eggs. Vaccines were formulated by adding Montanide ISA 70 VG oil (Seppic) according to the manufacturer's instructions. For each vaccine, three rats were intramuscularly vaccinated with 200 ml of each vaccine, given equal amounts of booster vaccinations 2 weeks after the initial vaccination, and slaughtered at week 4. The collected rat blood was centrifuged to separate serum containing polyclonal antibodies against the H5N1 viruses. The sera of each group of three rats were pooled to generate a single, bulk stock of antiserum against each of the eight viruses.
Antigenic variations analysis. The HI test was performed according to WHO protocols to screen the response of specific H5 mAbs against different H5N1viruses isolated from 2006 to 2011 (WHO, 2002) . The HI test was performed at a 1 : 100 dilution for mAbs and adsorbed with a 0.5 % suspension of chicken red blood cells. The collected sera from each vaccine preparation were subjected to HI assays to test against the homologous antigen and against the other viral antigens.
Antigenic cartography construction. Given any distance that is explicitly defined on the basis of the HI values, one can construct the corresponding antigenic cartography by using the integrative matrix completion multi-dimensional scaling MC-MDS method as described by Cai et al. (2010) . Matrix completion was used to remove the data noise in the HI experiment. Multi-dimensional scaling projected the antigens onto a two-dimensional grid.
HA sequencing and sequence analysis. The full-length HA of each virus isolate was sequenced by using an Illumina Genome Analyser. Sequences were compared by using BioEdit (Hall, 1999) and CLUSTAL W (Chenna et al., 2003) . Using MEGA 4.0.2, the phylogenetic tree was constructed by the neighbour-joining method and the reliability of each tree branch was estimated by performing 1000 bootstrap replicates (Tamura et al., 2007) . The sequences were submitted to GenBank under the following accession numbers: FJ472343, CY055191, CY061552, FR687255-FR687258 and CY099578-CY099593.
